Innovative Transcatheter Aortic Valve System by Suzhou Jiecheng Medical Receives NMPA Approval

Recently, the National Medical Products Administration approved CAUSPER MEDICAL INC.,"Transcatheter Aortic Valve System" Innovative Product Registration Application.

This product is designed for femoral artery access, featuring a movable positioning component that clamps native aortic valve leaflets, and a deflectable delivery system suitable for complex anatomical structures such as horizontal hearts. Applicable forSymptomatic, severe aortic valve regurgitation (severe aortic regurgitation) as assessed by the cardiac team in conjunction with a scoring system., orPatients with concurrent aortic valve stenosis who are not suitable for conventional surgical valve replacement and are aged 70 years or older.。